Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid

NCT02883894 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.

NCT NCT02883894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02883894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid
Lead sponsor
CHU de Reims
Phase
Observational
Overall status
Completed
Start date
November 30, 2009
Completion date
April 30, 2014
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bullous pemphigoid